176 related articles for article (PubMed ID: 16569757)
1. Thienorphine is a potent long-acting partial opioid agonist: a comparative study with buprenorphine.
Yu G; Yue YJ; Cui MX; Gong ZH
J Pharmacol Exp Ther; 2006 Jul; 318(1):282-7. PubMed ID: 16569757
[TBL] [Abstract][Full Text] [Related]
2. Ring-constrained orvinols as analogs of buprenorphine: differences in opioid activity related to configuration of C(20) hydroxyl group.
Traynor JR; Guo L; Coop A; Lewis JW; Woods JH
J Pharmacol Exp Ther; 1999 Dec; 291(3):1093-9. PubMed ID: 10565829
[TBL] [Abstract][Full Text] [Related]
3. [Structure-activity relationships analysis of thienorphine and its derivatives].
Yu G; Liu YS; Yan LD; Wen Q; Gong ZH
Yao Xue Xue Bao; 2009 Jul; 44(7):726-30. PubMed ID: 19806910
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.
Neilan CL; Husbands SM; Breeden S; Ko MC; Aceto MD; Lewis JW; Woods JH; Traynor JR
Eur J Pharmacol; 2004 Sep; 499(1-2):107-16. PubMed ID: 15363957
[TBL] [Abstract][Full Text] [Related]
5. Effect of thienorphine on the isolated uterine strips from pregnant rats.
Zhou P; Yan L; Yong Z; Yu G; Dong H; Yan H; Su R; Gong Z
Eur J Pharmacol; 2013 Mar; 703(1-3):83-90. PubMed ID: 23416213
[TBL] [Abstract][Full Text] [Related]
6. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
Kögel B; Christoph T; Strassburger W; Friderichs E
Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
[TBL] [Abstract][Full Text] [Related]
7. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
[TBL] [Abstract][Full Text] [Related]
8. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
9. Thienorphine: receptor binding and behavioral effects in rhesus monkeys.
Li JX; Becker GL; Traynor JR; Gong ZH; France CP
J Pharmacol Exp Ther; 2007 Apr; 321(1):227-36. PubMed ID: 17220427
[TBL] [Abstract][Full Text] [Related]
10. Multiple mechanisms underlying the long duration of action of thienorphine, a novel partial opioid agonist for the treatment of addiction.
Yu G; Li SH; Cui MX; Yan LD; Yong Z; Zhou PL; Su RB; Gong ZH
CNS Neurosci Ther; 2014 Mar; 20(3):282-8. PubMed ID: 24330593
[TBL] [Abstract][Full Text] [Related]
11. Reversibility of opioid receptor occupancy of buprenorphine in vivo.
Englberger W; Kögel B; Friderichs E; Strassburger W; Germann T
Eur J Pharmacol; 2006 Mar; 534(1-3):95-102. PubMed ID: 16490191
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of monoamine oxidase activity in the striatum of rats following chronic treatment of thienorphine.
Yong Z; Yan L; Wang X; Su R; Gong Z
Eur J Pharmacol; 2013 Aug; 713(1-3):44-6. PubMed ID: 23665497
[TBL] [Abstract][Full Text] [Related]
13. Thienorphine induces antinociception without dependence through activation of κ- and δ-, and partial activation of μ- opioid receptor.
Zhou P; Li Y; Yong Z; Chen M; Zhang Y; Su R; Gong Z
Brain Res; 2020 Dec; 1748():147083. PubMed ID: 32871137
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological mechanisms underlying the antinociceptive and tolerance effects of the 6,14-bridged oripavine compound 030418.
Wen Q; Yu G; Li YL; Yan LD; Gong ZH
Acta Pharmacol Sin; 2011 Oct; 32(10):1215-24. PubMed ID: 21863064
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine: new pharmacological aspects.
Cowan A
Int J Clin Pract Suppl; 2003 Feb; (133):3-8; discussion 23-4. PubMed ID: 12665117
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of 14-alkoxymorphinans. 21. Novel 4-alkoxy and 14-phenylpropoxy derivatives of the mu opioid receptor antagonist cyprodime.
Spetea M; Schüllner F; Moisa RC; Berzetei-Gurske IP; Schraml B; Dörfler C; Aceto MD; Harris LS; Coop A; Schmidhammer H
J Med Chem; 2004 Jun; 47(12):3242-7. PubMed ID: 15163203
[TBL] [Abstract][Full Text] [Related]
17. Partial versus full agonists for opioid-mediated analgesia--focus on fentanyl and buprenorphine.
Zuurmond WW; Meert TF; Noorduin H
Acta Anaesthesiol Belg; 2002; 53(3):193-201. PubMed ID: 12461829
[TBL] [Abstract][Full Text] [Related]
18. The antinociceptive activity of flupirtine: a structurally new analgesic.
Nickel B
Postgrad Med J; 1987; 63 Suppl 3():19-28. PubMed ID: 2833734
[TBL] [Abstract][Full Text] [Related]
19. Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist.
Huang P; Kehner GB; Cowan A; Liu-Chen LY
J Pharmacol Exp Ther; 2001 May; 297(2):688-95. PubMed ID: 11303059
[TBL] [Abstract][Full Text] [Related]
20. Novel depots of buprenorphine prodrugs have a long-acting antinociceptive effect.
Liu KS; Tzeng JI; Chen YW; Huang KL; Kuei CH; Wang JJ
Anesth Analg; 2006 May; 102(5):1445-51. PubMed ID: 16632824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
